We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current INSP market cap is 5.66B. The company's latest EPS is USD -0.7059 and P/E is -267.23.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 153.3M | 192.51M | 164.01M | 195.89M | 203.19M |
Operating Income | -13.47M | 9.3M | -15.22M | 5.1M | 14.32M |
Net Income | -8.54M | 14.76M | -10.01M | 9.79M | 18.5M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 82.05M | 115.38M | 233.39M | 407.86M | 624.8M |
Operating Income | -34.9M | -56.21M | -39.85M | -47.59M | -40.27M |
Net Income | -33.24M | -57.2M | -42.04M | -44.88M | -21.15M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 639.49M | 676.81M | 685.84M | 728.39M | 796.19M |
Total Liabilities | 95.31M | 104.3M | 96.82M | 90.32M | 99.63M |
Total Equity | 544.18M | 572.51M | 589.02M | 638.07M | 696.56M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 181.25M | 281.19M | 295.08M | 564.88M | 676.81M |
Total Liabilities | 41.42M | 51.44M | 66.04M | 68.87M | 104.3M |
Total Equity | 139.84M | 229.75M | 229.05M | 496.01M | 572.51M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 7.39M | 24.65M | 8.86M | 8.78M | 61.07M |
Investing | -143.1M | -294.82M | -19.54M | -13.92M | -116.88M |
Financing | 24.07M | 13.95M | 768k | 7.86M | 17.75M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -32.85M | -53.05M | -20.12M | 11.57M | 24.65M |
Investing | -43.56M | 86.63M | 29.14M | -19.6M | -294.82M |
Financing | 1.96M | 134.07M | 14.95M | 235.08M | 13.95M |
Market Cap | 5.66B |
Price to Earnings Ratio | -267.23 |
Price to Sales Ratio | 9.05 |
Price to Cash Ratio | 30.47 |
Price to Book Ratio | 9.87 |
Dividend Yield | - |
Shares Outstanding | 29.97M |
Average Volume (1 week) | 449.04k |
Average Volume (1 Month) | 593.44k |
52 Week Change | 34.81% |
52 Week High | 257.40 |
52 Week Low | 123.00 |
Spread (Intraday) | 10.78 (5.42%) |
Company Name | Inspire Medical Systems Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.inspiresleep.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions